You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Remove Import/Export filter Import/Export (1)
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- Remove OTC medicines filter OTC medicines (12)
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (5) Apply Prescription medicines filter
- Scheduling (55) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
- (-) Remove Import/Export filter Import/Export
- (-) Remove OTC medicines filter OTC medicines
Draft clinical evidence guidelines - Medical devices
Closed on 10 June 2016
Software as a Medical Device (IMDRF Working Group)
Closed on 27 May 2015
Proposed performance requirements and risk mitigation strategies for HIV tests
Closed on 30 January 2015
Software as a medical device (IMDRF working group)
Closed on 31 May 2014
Supply of in vitro diagnostic devices for self-testing (home testing) for the presence of human immunodeficiency virus in Australia
Closed on 6 May 2014
Proposed amendments to the new regulatory framework for In Vitro Diagnostic medical devices (IVDs)
Closed on 7 June 2013
Regulation Impact Statement: Changes to premarket assessment requirements for medical devices
Closed on 3 June 2013
Loratadine and desloratadine: proposed advisory statements for medicines
Closed on 7 December 2012
Fexofenadine and loperamide: proposed advisory statements for medicines
Closed on 4 June 2012
Reforms in the medical devices regulatory framework
Closed on 17 December 2010